Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric H1N1 vaccine study comparing Celvapan and Pandemrix
ISRCTN89141709Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Sep 2009
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 2 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza (2 arms), sponsored by University of Oxford. Primary endpoints: Four-fold rise in microneutralisation titre and Solicited local and fever reactogenicity. Started Sep 2009; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on ISRCTN89141709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN89141709.